THE APPLICATION OF OFFICIAL POLICY - PROPHYLAXIS RECOMMENDATIONS FOR PATIENTS WITH MITRAL-VALVE PROLAPSE

被引:11
作者
RETCHIN, SM
FLETCHER, RH
BUESCHER, PC
WAUGH, RA
BATTAGLINI, SW
机构
[1] DUKE UNIV, SCH MED, DEPT MED, DURHAM, NC 27706 USA
[2] UNIV N CAROLINA, SCH MED, DEPT MED, CHAPEL HILL, NC 27514 USA
关键词
D O I
10.1097/00005650-198510000-00004
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:1156 / 1162
页数:7
相关论文
共 30 条
[1]  
ALLEN H, 1974, BRIT HEART J, V36, P525
[2]   ENDOCARDITIS PROPHYLAXIS FOR PATIENTS WITH MITRAL-VALVE PROLAPSE - A QUANTITATIVE-ANALYSIS [J].
BOR, DH ;
HIMMELSTEIN, DU .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (04) :711-717
[4]  
CHEITLIN MD, 1980, CURRENT CONTROVERSIE, P434
[5]   A CONTROLLED EVALUATION OF THE RISK OF BACTERIAL-ENDOCARDITIS IN PERSONS WITH MITRAL-VALVE PROLAPSE [J].
CLEMENS, JD ;
HORWITZ, RI ;
JAFFE, CC ;
FEINSTEIN, AR ;
STANTON, BF .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (13) :776-781
[6]   CHEMOTHERAPY OF EXPERIMENTAL STREPTOCOCCAL ENDOCARDITIS .1. COMPARISON OF COMMONLY RECOMMENDED PROPHYLACTIC REGIMENS [J].
DURACK, DT ;
PETERSDORF, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (03) :592-598
[7]  
Fleiss JL, 1981, STATISTICAL METHODS, P217
[8]  
GEER AL, 1981, J MED SYST, V5, P129
[9]  
GREENLAND P, 1979, J MED EDUC, V54, P863
[10]   ADVANCES IN STUDY OF DIFFUSION OF INNOVATION IN HEALTH-CARE ORGANIZATIONS [J].
GREER, AL .
MILBANK MEMORIAL FUND QUARTERLY-HEALTH AND SOCIETY, 1977, 55 (04) :505-532